TY - JOUR
T1 - Distribution of Amniotic Epithelial Cells After Intraportal Infusion in a Rat Model
AU - Tanaka, Miyako
AU - Tokodai, Kazuaki
AU - Sato, Masato
AU - Yamada, Shuhei
AU - Okita, Hitomi
AU - Ito, Takako
AU - Saito, Masatoshi
AU - Hoshiai, Tetsuro
AU - Miyagi, Shigehito
AU - Miki, Toshio
AU - Unno, Michiaki
AU - Kamei, Takashi
AU - Goto, Masafumi
N1 - Funding Information:
This work was supported by The Clinical Research Promotion Program for Young Investigators of Tohoku University Hospital, Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics, The Japan Foundation for Pediatric Research, Public Trust Surgery Research Fund, and Takeda Science Foundation.
Publisher Copyright:
© 2021 Elsevier Inc.
PY - 2022/3
Y1 - 2022/3
N2 - Background: Human amniotic epithelial cells (hAECs) are increasingly gaining attention as novel sources for cell transplantation. In clinical practice, intraportal infusion is considered one of the leading approaches for transplantation; however, this has not yet been validated for in vivo transplantation of hAECs. Thus, this study aims to investigate the distribution of hAECs post intraportal infusion and compare this distribution with other cell administration routes. Methods: Wistar/ST rats were divided into 4 groups (n = 3 for each) based on cell administration route: group 1, intraportal; group 2, the spleen; group 3, tail veins; and group 4, penile veins. Subsequently, hAECs (1 × 107) stained with XenoLight DiR were infused into each recipient. Cell distribution was evaluated using an in vivo imaging system. Results: DiR signals were detected in the rat livers of groups 1 and 2 with those in group 2 being much weaker than those in group 1. Necrosis of small intestine was observed in 2 cases in group 2. DiR signals were detected in the lungs in groups 3 and 4 because of systemic circulation; however, all the animals died within 20 minutes of infusions. Conclusions: Intraportal infusion is potentially applicable for safe and efficient transplantation of hAECs into the liver, whereas hAECs administration via the spleen carries a risk of thrombosis in a narrow portal vein system. Our results also indicate that hAECs administration via the systemic circulation could cause pulmonary embolism in clinical settings.
AB - Background: Human amniotic epithelial cells (hAECs) are increasingly gaining attention as novel sources for cell transplantation. In clinical practice, intraportal infusion is considered one of the leading approaches for transplantation; however, this has not yet been validated for in vivo transplantation of hAECs. Thus, this study aims to investigate the distribution of hAECs post intraportal infusion and compare this distribution with other cell administration routes. Methods: Wistar/ST rats were divided into 4 groups (n = 3 for each) based on cell administration route: group 1, intraportal; group 2, the spleen; group 3, tail veins; and group 4, penile veins. Subsequently, hAECs (1 × 107) stained with XenoLight DiR were infused into each recipient. Cell distribution was evaluated using an in vivo imaging system. Results: DiR signals were detected in the rat livers of groups 1 and 2 with those in group 2 being much weaker than those in group 1. Necrosis of small intestine was observed in 2 cases in group 2. DiR signals were detected in the lungs in groups 3 and 4 because of systemic circulation; however, all the animals died within 20 minutes of infusions. Conclusions: Intraportal infusion is potentially applicable for safe and efficient transplantation of hAECs into the liver, whereas hAECs administration via the spleen carries a risk of thrombosis in a narrow portal vein system. Our results also indicate that hAECs administration via the systemic circulation could cause pulmonary embolism in clinical settings.
UR - http://www.scopus.com/inward/record.url?scp=85122948191&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85122948191&partnerID=8YFLogxK
U2 - 10.1016/j.transproceed.2021.09.077
DO - 10.1016/j.transproceed.2021.09.077
M3 - Article
C2 - 35039159
AN - SCOPUS:85122948191
SN - 0041-1345
VL - 54
SP - 513
EP - 515
JO - Transplantation Proceedings
JF - Transplantation Proceedings
IS - 2
ER -